Ernesto Freire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ernesto Freire has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Arne Schön
Department of Biology, Johns Hopkins University, 3400 North Charles, Baltimore, MD, 21218, USA
15 shared publications- Adrián Velázquez-Campoy
Universidad de Zaragoza
8 shared publications - L. Mario Amzel
Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, USA
6 shared publications Yoshiaki Kiso
Department of Medicinal Chemistry, Center for Frontier Research in Medicinal Science, Kyoto Pharmaceutical University, Yamashina‐ku, Kyoto 607‐8412, Japan
6 shared publicationsBenjamin R. Clarkson
Department of Biology, Johns Hopkins University, 3400 North Charles, Baltimore, MD, 21218, United States
5 shared publicationsYuko Kawasaki
Department of Biology, Johns Hopkins University, Baltimore, MD 21218, USA
4 shared publications
Latest Publications
- 19 April 2024
- Published by Elsevier in Analytical Biochemistry
- Vol. 691, 115533
Extrapolating differential scanning calorimetry data for monoclonal antibodies to low temperatures
- 19 April 2024
- Published by Elsevier in Analytical Biochemistry
- Vol. 691, 115533
Extrapolating differential scanning calorimetry data for monoclonal antibodies to low temperatures
- 1 August 2021
- Published by Elsevier in Analytical Biochemistry
- Vol. 626, 114240
Reversibility and irreversibility in the temperature denaturation of monoclonal antibodies
- 1 August 2021
- Published by Elsevier in Analytical Biochemistry
- Vol. 626, 114240
Reversibility and irreversibility in the temperature denaturation of monoclonal antibodies
- 22 July 2020
- Published by Springer Nature
- Vol. 2141, 449-462
Binding Thermodynamics to Intrinsically Disordered Protein Domains
Many proteins are intrinsically disordered or contain one or more disordered domains. These domains can participate in binding interactions with other proteins or small ligands. Binding to intrinsically disordered protein domains requires the folding or structuring of those regions such that they can establish well-defined stoichiometric interactions. Since, in such a situation binding is coupled to folding, the energetics of those two events is reflected in the measured binding thermodynamics. In this protocol, we illustrate the thermodynamic differences between binding coupled to folding and binding independent of folding for the same protein. As an example, we use the HIV-1 envelope glycoprotein gp120 that contains structured as well as disordered domains. In the experiments presented, the binding of gp120 to molecules that bind to disordered regions and trigger structuring (CD4 or MAb 17b) and to molecules that bind to structured regions and do not induce conformational structuring (MAb b12) is discussed.
- 22 July 2020
- Published by Springer Nature
- Vol. 2141, 449-462
Binding Thermodynamics to Intrinsically Disordered Protein Domains
Many proteins are intrinsically disordered or contain one or more disordered domains. These domains can participate in binding interactions with other proteins or small ligands. Binding to intrinsically disordered protein domains requires the folding or structuring of those regions such that they can establish well-defined stoichiometric interactions. Since, in such a situation binding is coupled to folding, the energetics of those two events is reflected in the measured binding thermodynamics. In this protocol, we illustrate the thermodynamic differences between binding coupled to folding and binding independent of folding for the same protein. As an example, we use the HIV-1 envelope glycoprotein gp120 that contains structured as well as disordered domains. In the experiments presented, the binding of gp120 to molecules that bind to disordered regions and trigger structuring (CD4 or MAb 17b) and to molecules that bind to structured regions and do not induce conformational structuring (MAb b12) is discussed.
- 1 October 2018
- Published by Elsevier in Analytical Biochemistry
- Vol. 558, 50-52
Isothermal calorimetry of a monoclonal antibody using a conventional differential scanning calorimeter
- 1 October 2018
- Published by Elsevier in Analytical Biochemistry
- Vol. 558, 50-52
Isothermal calorimetry of a monoclonal antibody using a conventional differential scanning calorimeter
- 1 August 2018
- Published by Elsevier in Analytical Biochemistry
- Vol. 554, 61-69
Long term stability of a HIV-1 neutralizing monoclonal antibody using isothermal calorimetry
- 1 August 2018
- Published by Elsevier in Analytical Biochemistry
- Vol. 554, 61-69
Long term stability of a HIV-1 neutralizing monoclonal antibody using isothermal calorimetry
- 19 July 2017
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 85 (11) , 2009-2016
Temperature stability of proteins: Analysis of irreversible denaturation using isothermal calorimetry
The structural stability of proteins has been traditionally studied under conditions in which the folding/unfolding reaction is reversible, since thermodynamic parameters can only be determined under these conditions. Achieving reversibility conditions in temperature stability experiments has often required performing the experiments at acidic pH or other nonphysiological solvent conditions. With the rapid development of protein drugs, the fastest growing segment in the pharmaceutical industry, the need to evaluate protein stability under formulation conditions has acquired renewed urgency. Under formulation conditions and the required high protein concentration (∼100 mg/mL), protein denaturation is irreversible and frequently coupled to aggregation and precipitation. In this article, we examine the thermal denaturation of hen egg white lysozyme (HEWL) under irreversible conditions and concentrations up to 100 mg/mL using several techniques, especially isothermal calorimetry which has been used to measure the enthalpy and kinetics of the unfolding and aggregation/precipitation at 12°C below the transition temperature measured by DSC. At those temperatures the rate of irreversible protein denaturation and aggregation of HEWL is measured to be on the order of 1 day−1. Isothermal calorimetry appears a suitable technique to identify buffer formulation conditions that maximize the long term stability of protein drugs.
- 19 July 2017
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 85 (11) , 2009-2016
Temperature stability of proteins: Analysis of irreversible denaturation using isothermal calorimetry
The structural stability of proteins has been traditionally studied under conditions in which the folding/unfolding reaction is reversible, since thermodynamic parameters can only be determined under these conditions. Achieving reversibility conditions in temperature stability experiments has often required performing the experiments at acidic pH or other nonphysiological solvent conditions. With the rapid development of protein drugs, the fastest growing segment in the pharmaceutical industry, the need to evaluate protein stability under formulation conditions has acquired renewed urgency. Under formulation conditions and the required high protein concentration (∼100 mg/mL), protein denaturation is irreversible and frequently coupled to aggregation and precipitation. In this article, we examine the thermal denaturation of hen egg white lysozyme (HEWL) under irreversible conditions and concentrations up to 100 mg/mL using several techniques, especially isothermal calorimetry which has been used to measure the enthalpy and kinetics of the unfolding and aggregation/precipitation at 12°C below the transition temperature measured by DSC. At those temperatures the rate of irreversible protein denaturation and aggregation of HEWL is measured to be on the order of 1 day−1. Isothermal calorimetry appears a suitable technique to identify buffer formulation conditions that maximize the long term stability of protein drugs.
- 1 November 2016
- Published by Elsevier in Analytical Biochemistry
- Vol. 513, 1-6
Enthalpy screen of drug candidates
- 1 November 2016
- Published by Elsevier in Analytical Biochemistry
- Vol. 513, 1-6
Enthalpy screen of drug candidates
- 1 May 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1860 (5) , 975-980
Three easy pieces
- 1 May 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1860 (5) , 975-980
Three easy pieces
- 1 February 2016
- Published by Elsevier in Drug Discovery Today
- Vol. 21 (2) , 342-347
Conformational stability and self-association equilibrium in biologics
- 1 February 2016
- Published by Elsevier in Drug Discovery Today
- Vol. 21 (2) , 342-347
Conformational stability and self-association equilibrium in biologics
- 1 November 2015
- Published by Elsevier in Analytical Biochemistry
- Vol. 488, 45-50
Denatured state aggregation parameters derived from concentration dependence of protein stability
- 1 November 2015
- Published by Elsevier in Analytical Biochemistry
- Vol. 488, 45-50
Denatured state aggregation parameters derived from concentration dependence of protein stability